For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250109:nRSI8211Sa&default-theme=true
RNS Number : 8211S Tate & Lyle PLC 09 January 2025
9 January 2025
Tate & Lyle PLC
Completion of Share Buyback Programme
Tate & Lyle PLC announces the completion of its non-discretionary share
buyback programme of £215 million, initially announced on 19 June 2024 (the
"Programme").
A total of 31,294,579 ordinary Tate & Lyle PLC shares were purchased with
an aggregate market value equivalent of £214,989,726. Following the purchase
of these shares, the Company has 445,429,642 ordinary shares in issue
(excluding treasury shares).
End
For more information contact:
For Tate & Lyle PLC
Investors and analysts
Christopher Marsh, VP Investor Relations
Tel: Mobile: +44 (0) 7796 192 688
About Tate & Lyle PLC:
Supported by our 165-year history of ingredient innovation, we partner with
customers to provide consumers with healthier and tastier choices when they
eat and drink. We are proud that millions of people around the world consume
products containing our ingredients and solutions every day.
Through our leading expertise in sweetening, mouthfeel and fortification, we
develop ingredients and solutions which reduce sugar, calories and fat, add
fibre and protein, and provide texture and stability to food and drink in
categories including beverages, dairy, bakery, snacks, soups, sauces, and
dressings.
Tate & Lyle recently acquired CP Kelco, a leading provider of pectin,
speciality gums and other nature-based ingredients to create a leader in
mouthfeel, significantly enhancing our solutions capabilities. Following this
combination, we now have more than 5,000 employees working in around 75
locations in 39 countries, serving customers in more than 120 countries.
Science, Solutions, Society is our brand promise and how we will achieve our
purpose of Transforming Lives through the Science of Food. By living our
purpose, we believe we can successfully grow our business and have a positive
impact on society. We live our purpose in three ways, by supporting healthy
living, building thriving communities and caring for our planet.
Tate & Lyle is listed on the London Stock Exchange under the symbol
TATE.L. American Depositary Receipts trade under TATYY. For the year ended 31
March 2024, and on a pro forma basis which assumes for illustrative purposes
that the combination with CP Kelco took place on 1 April 2023, revenue for the
enlarged Tate & Lyle Group would have been £2.25 billion. For more
information, please visit www.tateandlyle.com
(https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Ftracking.tateandlyle.com%2Ftracking%2Fclick%3Fd%3D3cSjCOQpDDIy0k84YD47Ezw3MaegKthKriQsWZReNL-qkzauWWHlbq1pb7ZT4OBB7J16dZSOkzjgBJXkNbuN3kN03V9NiKzIy5MPNEdPndqy2BCH3ovx3-gTj1Xkr8bhUzIP5u80CvC86fPCzTieCn09hoGDMGOKZQ8L_F6zjHZF0&data=05%7C02%7CBecky.Wright%40tateandlyle.com%7C41ec9cf52af94ee2311208dd2fff4561%7C39cc8f4f7ada4a2a9685c30a4321498c%7C0%7C0%7C638719495616319895%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=epxit6vODC73keApUQL%2Fhll7lIup0CIoVUVRCxPLXAw%3D&reserved=0)
or follow Tate & Lyle on LinkedIn
(https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Ftracking.tateandlyle.com%2Ftracking%2Fclick%3Fd%3DABnUkBC-haLSfYKJr4iejQlGGvVPM0XOmwN-F8IvaxDcxJuYDKI5A-1Q_-9RFhr_gsDPLTDyNsKtJff4nn-0XFVzdmKBWWKVfKlxja5CkXpEylSgvUKB5DchY1mtFFtHWatETf2Is7t_iH_8SFleQ3-K3aTgl1CGgz5a9Iv1RKx80&data=05%7C02%7CBecky.Wright%40tateandlyle.com%7C41ec9cf52af94ee2311208dd2fff4561%7C39cc8f4f7ada4a2a9685c30a4321498c%7C0%7C0%7C638719495616342464%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=T4wF9oO8dFLWfwaV7Q8kk1kAYuLM7AjVmbtOAZxZQl4%3D&reserved=0)
, X (Twitter)
(https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Ftracking.tateandlyle.com%2Ftracking%2Fclick%3Fd%3DYxrwqmAN_KwTHCUchykvisyDCKhDIhn5Qos6_xn2xf-Rbd_aAZM1G6tGPM_JtS4ungCBCZ5TyE-6q9g0MYXqbyB73YgozP1VRvTneb8zACwQBNAgZY4D-3dK_cAfcTidDsQ4NNk1OOjok2XxwiJ2ZEY1&data=05%7C02%7CBecky.Wright%40tateandlyle.com%7C41ec9cf52af94ee2311208dd2fff4561%7C39cc8f4f7ada4a2a9685c30a4321498c%7C0%7C0%7C638719495616358900%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=rFHJOOCKfYNAHQQ1YryEa201AHvlcoK%2ByymUtevhvik%3D&reserved=0)
, Facebook
(https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Ftracking.tateandlyle.com%2Ftracking%2Fclick%3Fd%3D3cSjCOQpDDIy0k84YD47Ezw3MaegKthKriQsWZReNL-qkzauWWHlbq1pb7ZT4OBB7J16dZSOkzjgBJXkNbuN3nhfpIggpFkofxGK4yI9ydx5XPZ7zdOScH4x1dXCwA5uSXFCcBZpw2zKnP68L0KvnSJ0E2YYmUnPg4i81xXoO6kx0&data=05%7C02%7CBecky.Wright%40tateandlyle.com%7C41ec9cf52af94ee2311208dd2fff4561%7C39cc8f4f7ada4a2a9685c30a4321498c%7C0%7C0%7C638719495616375528%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=5oXAyImUeCtcItCTsNIBR8acN7x1t%2FQnGZse9t6rgLY%3D&reserved=0)
or YouTube
(https://eur03.safelinks.protection.outlook.com/?url=http%3A%2F%2Ftracking.tateandlyle.com%2Ftracking%2Fclick%3Fd%3D0QLiMNnVJBZN7gwguzMGMpWcul7ue0hr3OhZ9u99icbMXWbYm9lPqNPiHcWgEm9vQEqQW4Wau5Q6sWJ42c1NNhuuvtQLToWTTffAFAXiaRjcC69U_L1_y3I-fnLdo7eCnuWsNG6jmQbbnoUaB5i_nA41&data=05%7C02%7CBecky.Wright%40tateandlyle.com%7C41ec9cf52af94ee2311208dd2fff4561%7C39cc8f4f7ada4a2a9685c30a4321498c%7C0%7C0%7C638719495616391929%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=C1PxHryp34sWKaFT3e4Zm6RU6GSszBNaE1ZOtOcyGa0%3D&reserved=0)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCPKCBPOBKDBDK